メニューにジャンプコンテンツにジャンプ

トップページ > 研究資源部 > 研究実績 > 2021年 研究業績

2021年 研究業績

  1. Sakane N, Oshima Y, Kotani K, Suganuma A, Takahashi K, Sato J, Suzuki S, Izumi K, Kato M, Noda M, Kuzuya H.
    Impact of telephone support programme using telemonitoring on stage of change towards healthy eating and active exercise in people with prediabetes.
    J Telemed Telecare: Jun;27(5):307-313, 2021.
  2. Hara H, Uemura Y, Hayakawa K, Togano T, Asai Y, Matsunaga N, Terada M, Ohtsu H, Kitajima K, Shimizu Y, Sato L, Ishikane M, Kinoshita-Iwamoto N, Shibata T, Kondo M, Izumi K, Sugiura W, Ohmagari N:
    Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan.
    Int J Infect Dis. Nov;112:111-116, 2021.
    doi: 10.1016/j.ijid.2021.09.014. Epub 2021 Sep 10.
  3. Matsunaga N, Hayakawa K, Terada M, Ohtsu H, Asai Y, Tsuzuki S, Suzuki S, Toyoda A, Suzuki K, Endo M, Fujii N, Suzuki M, Saito S, Uemura Y, Shibata T, Kondo M, Izumi K, Terada-Hirashima J, Mikami A, Sugiura W, Ohmagari N:
    Clinical Epidemiology of Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan.
    Clin Infect Dis. Dec 6;73(11):e3677-e3689, 2021.
    doi: 10.1093/cid/ciaa1470.
  4. Matsunaga N, Hayakawa K, Asai Y, Tsuzuki S, Terada M, Suzuki S, Ohtsu H, Kitajima K, Toyoda A, Suzuki K, Suzuki M, Saito S, Uemura Y, Shibata T, Kondo M, Nakamura-Uchiyama F, Yokota K, Saito F, Izumi K, Sugiura W, Ohmagari N:
    Clinical characteristics of the first three waves of hospitalised patients with COVID-19 in Japan prior to the widespread use of vaccination: a nationwide observational study. Lancet Reg Health West Pac. Mar 16;22:100421, 2022.
    doi: 10.1016/j.lanwpc.2022.100421. eCollection 2022 May.
  5. Tsuzuki S, Hayakawa K, Doi Y, Shinozaki T, Uemura Y, Matsunaga N, Terada M, Suzuki S, Asai Y, Yamada G, Saito S, Shibata T, Kondo M, Izumi K, Hojo M, Mizoue T, Yokota K, Nakamura-Uchiyama F, Saito F, Sugiura W, Ohmagari N:
    Effectiveness of Favipiravir on Nonsevere, Early-Stage COVID-19 in Japan: A Large Observational Study Using the COVID-19 Registry Japan.
    Infect Dis Ther. Mar 21:1-13, 2022.
    doi: 10.1007/s40121-022-00617-9. Online ahead of print.
  6. Kimura M, Asano-Mori Y, Sakoh T, Abe M, Ueno K, Hoshino Y, Nakamura S, Umeyama T, Yamagoe S, Miyazaki Y, Baba M, Okada C, Ogura S, Mitsuki T, Yamaguchi K, Yuasa M, Kaji D, Kageyama K, Nishida A, Taya Y, Ishiwata K, Takagi S, Yamamoto H, Yamamoto G, Uchida N, Wake A, Taniguchi S, Araoka H.
    Factors Associated with Breakthrough Fungemia Caused by Candida, Trichosporon, or Fusarium Species in Patients with Hematological Disorders.
    Antimicrobial agents and chemotherapy 66(3) 15 Mar 2022.